 |
인쇄하기
취소
|
Handok to launch Teveten, an anti-hypertension drug.
Handok announced on Oct. 15 to launch Teveten, an anti-hypertensive drug (Eprosartan) originally developed by Solvay, a Belgium company.
Teveten is a new alpha receptor blocker having a dual mode of action, which shows the angiotensin II receptor blocking (RAAS) with sympathetic nerve blocking activities.
It has specific effects of lowering the systolic pressure with excellent tolerance, ...
Teveten is a new alpha receptor blocker having a dual mode of action, which shows the angiotensin II receptor blocking (RAAS) with sympathetic nerve blocking activities.
It has specific effects of lowering the systolic pressure with excellent tolerance, ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.